Chemical Compound

2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-6-(2,2,2-trifluoroethoxy)-3-pyridinyl)-

CAS Registry Number 1869057-83-9
2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-6-(2,2,2-trifluoroethoxy)-3-pyridinyl)- 结构式
Primary record

2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-6-(2,2,2-trifluoroethoxy)-3-pyridinyl)-

库存
1,490 克
纯度
98.5 %
CAS
1869057-83-9

化合物标识与属性

CAS
1869057-83-9
PubChem CID
118861389
SMILES
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(N=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OCC(F)(F)F
Canonical SMILES
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OCC(F)(F)F)nc1N(C)CCN(C)C

名称与同义词

  • Alflutinib
  • furmonertinib
  • firmonertinib
  • Aflutinib
  • Ivesa
  • Alflutinib?
  • AST2818
  • 1869057-83-9
  • firmonertinib [INN]
  • AST-2818
  • alflutinib (pseudo INN)
  • Firmonertinib [WHO-DD]
  • RefChem:915390
  • A49A7A5YN4
  • Firmonertinib (USAN/INN)
  • FIRMONERTINIB [USAN]
  • UNII-A49A7A5YN4
  • ASTX295
  • ASTX-295
  • orb1306046
  • CHEMBL4297258
  • SCHEMBL17490447
  • SCHEMBL29386562
  • GTPL10477
  • GHKOONMJXNWOIW-UHFFFAOYSA-N
  • AST 2818
  • BCP30339
  • UZC05783
  • ASK120067
  • example 3 [US10072002B2]
  • NSC856804
  • AKOS040745008
  • AT42596
  • EX-A2868-1
  • NSC-856804
  • AC-36862
  • TS-08244
  • HY-112870
  • Alflutinib(AST2818;AST-2818;ASK120067)
  • J3.757.702B
  • D12956
  • N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-6-(2,2,2-trifluoroethoxy)pyridin-3-yl]prop-2-enamide
  • Alflutinib, AST-2818, AST2818, AST 2818
  • N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)acrylamide
  • FIRMONERTINIB (SYNONYMS: ALFLUTINIB; FURMONERTINIB; AST2818)
  • 2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-6-(2,2,2-trifluoroethoxy)-3-pyridinyl)-
  • Alflutinib;AST-2818;AST 2818;ASK120067;ASK 120067;ASK-120067
  • N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)prop-2-enamide
  • 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-6-(2,2,2-trifluoroethoxy)-3-pyridinyl]-
  • AFU
  • N-(2-(2-(dimethylamino)ethyl-methylamino)-5-((4-(1-methylindol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)prop-2-enamide
  • N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)prop-2-enamide
  • N-[2-[[2-(dimethylamino)ethyl]methylamino]-5-[[4-(1-methyl-1H-indol-3-yl)-2- pyrimidinyl]amino]-6-(2,2,2-trifluoroethoxy)-3-pyridinyl]-2-Propenamide
  • N-[2-[[2-(Dimethylamino)ethyl]methylamino]-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-6-(2,2,2-trifluoroethoxy)-3-pyridinyl]-2-propenamide
  • N-[2-{[2-(dimethylamino)ethyl](methyl)amino}-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}-6-(2,2,2-trifluoroethoxy)pyridin-3-yl]prop-2-enamide